2018 Maryland Code
Health - General
Title 18 - Disease Prevention
Subtitle 10 - Hepatitis C Virus
§ 18-1001. Assessment and information program

    As funds are available, the Department shall:
  • (1) Conduct a needs assessment to determine the incidence of the hepatitis B virus and hepatitis C virus in the State;

  • (2) Initiate a statewide public awareness campaign targeting vulnerable populations and health care providers in the State to urge hepatitis B virus and hepatitis C virus education and testing;

  • (3) Coordinate with other units of State government, including the Department of Public Safety and Correctional Services and the Veterans' Administration, to activate a hepatitis C virus plan for the education, testing, and treatment of the populations within the jurisdiction of the units;

  • (4) Solicit funding from the private sector and units of federal, State, and local government for hepatitis B virus and hepatitis C virus outreach;

  • (5) Provide funding for hepatitis C virus pilot programs, which may include programs in methadone clinics or programs for the Department of Correctional Services population;

  • (6) Review and recommend initiatives to promote advocacy, education, physician outreach, and awareness of the hepatitis B virus and hepatitis C virus;

  • (7) Assess the feasibility of creating a Hepatitis C Virus Administration in the Department and examine methods to maximize existing resources to raise awareness of the hepatitis C virus;

  • (8) Implement the 2005 Report of the Hepatitis C Advisory Council;

  • (9) Coordinate with the Maryland Office of Minority Health and Health Disparities to develop a hepatitis B virus plan and a hepatitis C virus plan for the education, testing, and treatment of high risk populations and ethnic and racial populations who are affected disproportionately by the hepatitis B and hepatitis C viruses, including the Asian population and African immigrants;

  • (10) Develop a plan to increase the availability of hepatitis B virus vaccinations in the State, in accordance with recommendations from the Centers for Disease Control and Prevention;

  • (11) Develop recommendations to improve the awareness and the affordability of medications for treating the hepatitis C virus; and

  • (12) Collaborate with the Maryland Insurance Administration to make recommendations regarding insurance coverage for the treatment of the hepatitis C virus.

Disclaimer: These codes may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.